Needham downgrades Biogen on slow growth of Alzheimer's drug
- Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's drug, Leqembi, and a lack of major catalysts over the...
- Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's drug, Leqembi, and a lack of major catalysts over the...
ServiceTitan (TTAN) has filed for a proposed IPO. The company describes itself as: "We are modernizing a massive and technologically underserved industry—an industry commonly...
By Sriparna Roy (Reuters) -CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate...
Harmonic Inc. shares rose Monday, currently up around 1.6% following pressure from activist investor Ancora Holdings Group, which has called for the company to...
– Norway stocks were lower after the close on Monday, as losses in the Media, Transport and Diversified Financials sectors led shares lower. At the close in Oslo,...
(Reuters) -Australia's competition regulator said on Monday it is seeking views on the Macquarie-backed telecommunications group Vocus' A$5.25 billion ($3.39 billion) takeover of...
– Israel stocks were lower after the close on Monday, as losses in the Banking, Financials and Real Estate sectors led shares lower. At the close in Tel Aviv, the TA...
– Greece stocks were lower after the close on Monday, as losses in the Telecoms, Household and Basic Resources sectors led shares lower. At the close in Athens, the...
Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to Buy while trimming the target price...
Mizuho analysts raised their estimates and price target for Dell Technologies (NYSE:DELL), highlighting its increasing share in the AI server market as NVIDIA...